GERON CORP - 8-K Filing

Geron Corporation discontinues Phase 3 IMpactMF trial of imetelstat following recommendation from independent Data Monitoring Committee. (Items: 8.01 Other Events On October 28, 2026, Geron Corporation (the “Company”) issued a press release announcing an update on the Phase 3 IMpactMF trial, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $GERN

Read the full article at SEC EDGAR

Part of the story GERON CORP - 8-K Filing (3 articles)

More Regulatory news